NPB-001-056

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNPB-001-056
Drug Alias NameNPB-001-056NPB-001056NPB-001-05NPB-001-05-Bcr-AblNPB-001-056-Bcr-Abl
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPiramal Phytocare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPiramal Phytocare
Active IndicationsN/A
Inactive IndicationsLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksN/A